Pakistan Medicines & Pharma IntelligenceMedicine data  •  Company portfolios  •  Price records
MedInfoBaseMedicines · Evidence · Intelligence
Home / Brand
Brand / product

REVOSIROX

DEFERRASIROX · 250 mg

Current listed pricePKR 8,054.70Effective 2026-07-22

Product details

Generic
DEFERRASIROX
Therapeutic class
ATC
Strength
250 mg
Dosage form
Tablet
Pack
3x10's
Registration no.
091027
Verification
2026-08-08

Manufacturer

Kaizen Pharmaceuticals (Pvt) Ltd

Explore this manufacturer's complete MedInfoBase portfolio, generics and current listed prices.

View company portfolio →
Traceability

Official price history

AmountEffective fromVerifiedSourceStatus
PKR 8,054.702026-07-222026-08-08DRAP PharmaPrice IndexCurrent
PKR 7,862.812026-07-222026-08-08DRAP PharmaPrice IndexHistorical
Same generic

Alternative listed brands

Price note: MedInfoBase displays source-listed prices where available. A pharmacy's transaction price may differ. Verify current regulatory and product information before professional use.